scholarly journals Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials

2018 ◽  
Vol 7 (4) ◽  
pp. 473-484 ◽  
Author(s):  
Tram T. Tran ◽  
Darshan Mehta ◽  
Federico Mensa ◽  
Caroline Park ◽  
Yanjun Bao ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Renal Function ◽  
Hepatitis C ◽  
Phase 3 ◽  
Hepatitis C Treatment ◽  
Post Hoc Analysis ◽  
Metabolic Outcomes ◽  
Stable Renal Function ◽  
Post Hoc

scholarly journals Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials

2021 ◽  
Author(s):  
Mark G. Lebwohl ◽  
Ahmed M. Soliman ◽  
Hongbo Yang ◽  
Jessie Wang ◽  
Kaitlin Hagan ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Severe Psoriasis ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document